Joel Isaacson & Co., LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2016$58,000
-10.8%
1,5110.0%0.01%
-7.7%
Q3 2016$65,0000.0%1,5110.0%0.01%
-7.1%
Q2 2016$65,000
-1.5%
1,511
-7.0%
0.01%
-6.7%
Q1 2016$66,0000.0%1,6240.0%0.02%
-6.2%
Q4 2015$66,0000.0%1,624
-4.7%
0.02%
-11.1%
Q3 2015$66,000
-7.0%
1,7040.0%0.02%0.0%
Q2 2015$71,000
-10.1%
1,7040.0%0.02%
-10.0%
Q1 2015$79,000
+8.2%
1,704
+0.1%
0.02%0.0%
Q4 2014$73,000
+1.4%
1,703
+8.5%
0.02%
-9.1%
Q3 2014$72,000
-14.3%
1,5690.0%0.02%
-15.4%
Q2 2014$84,0000.0%1,5690.0%0.03%
-7.1%
Q1 2014$84,0000.0%1,5690.0%0.03%
-6.7%
Q4 2013$84,000
-54.3%
1,569
-57.2%
0.03%
-60.0%
Q3 2013$184,000
+0.5%
3,6690.0%0.08%
-12.8%
Q2 2013$183,000
+6.4%
3,6690.0%0.09%
-1.1%
Q1 2013$172,000
+8.2%
3,6690.0%0.09%
-16.3%
Q4 2012$159,0003,6690.10%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2014
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders